PRESS RELEASE: Luneau Technology aquires Next Sight to enter telehealth market

Pont de l’Arche, the 11th October 2019

Luneau Technology group announces today a new acquisition in Europe: Next Sight, an Italian company specialized in retinal screening and telehealth.

 This acquisition brings to Luneau increased capabilities – covering both Back and Front of the eye – to propose a comprehensive eye exam, which is a key customer need. It supports and brings a set of experience and technology which will help to drive forward a focus on a range of telehealth solutions for Luneau Technology group.

Marc Abitbol, PhD – President and CEO Luneau Technology

“It is a great opportunity for Luneau Technology to expand our offer. We are very excited to enter the telehealth space and welcome Paola
among our management team to lead this new capability for the group.”

Paola Griggio, PhD and MBA - CEO of Next Sight

Paola will continue to manage future initiatives around retinal topics, but she will also take up a key leadership role as she is appointed VP
Telehealth for Luneau Technology group.

The complementary activities among the two companies and their respective experience will allow the Luneau Technology group to meet even better the expectations of the visual health sector.

In recent years, Luneau Technology group has made significant acquisitions in the USA and Europe tonsustain its growth and allow to further increase its proximity to ECP (Eye Care Professional) and its responsiveness to market expectations.

The acquisition of Next Sight is fully in line with its strategic plans and the company’s ambition for the future.

THE PARTNERS :

Luneau Technology

Develops, manufactures, and markets innovative devices aimed at ophthalmic, optometrists, and optical professionals with products on WAVE FRONT technology. Its brand Visionix proposes refraction, diagnostic and screening instruments (such as the recently launched Vx 120 + Dry Eye or
the Eye Refract), while Briot and Weco focus on finishing products.

Next Sight

An Italian company based in Padova, that develops robotic and IT technologies to provide ophthalmic diagnostic solutions. Next Sight produces Nexy, a device which allows retina screening through a platform to securely send patient data to remote locations. Therefore Nexy combines robotic
technology, telehealth platform, image management solutions and secured data transfer.

Download Now the official Press Release

File name: Press-release-Next_Sight-October2019-EN.pdf

359 70